Drugs / GIP-A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02747472 | Apr → Jul 2016 | glucose metabolism disease | University Hospital, Gentofte, Copenhagen | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GIP-A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02747472 ↗ |
| Action | Inhibit | “GIP receptor antagonist” NCT02747472 ↗ |
| Modality | Peptide | “peptide-based competitive GIP receptor antagonist GIP-A” NCT02747472 ↗ |